Maintaining normal lung function in children with cystic fibrosis is possible with aggressive treatment regardless of Pseudomonas aeruginosa infections

Acta Paediatr. 2021 Sep;110(9):2607-2609. doi: 10.1111/apa.15880. Epub 2021 May 5.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Cystic Fibrosis* / complications
  • Cystic Fibrosis* / therapy
  • Humans
  • Lung / diagnostic imaging
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas Infections* / etiology
  • Pseudomonas aeruginosa
  • Respiratory Tract Infections*

Substances

  • Anti-Bacterial Agents

Grants and funding